Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Daiichi Sankyo
With
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female Europeans aged 18 years or older with moderate to severe HTN, defined as follows (conventional BP measurements)
You may not be if
Female patients of childbearing potential pregnant, lactating or planning to become pregnant during the trial period.
Patients with serious disorders which may limit the ability to evaluate the efficacy or safety of the study medication, including cerebrovascular, cardiovascular, renal, respiratory, hepatic, gastrointestinal, endocrine or metabolic, haematological or oncological, neurological and psychiatric diseases.
Patients having a history of the following within the last six months:
* myocardial infarction,
* unstable angina pectoris,
* percutaneous coronary intervention,
* severe heart failure,
* hypertensive encephalopathy, cerebrovascular accident (stroke) or
* transient ischaemic attack.
Patients with clinically significant abnormal laboratory values at screening.
